Gene therapy digest – 2021 Gene therapy digest – 2021 Eyevensys’ gene therapies get a financial boost EYS809 (Anti-angiogenic & anti-fibrotic; Preclinical), EYS611 (Antioxidant; IND-enabling) Series B Plus funding – $12M and Korea Investment Partners is the key investor Eyevensys’ […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id